Ionic Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Ionic Capital Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-9,650	Closed	-$953K	–	169
2024 Q3	$953K	Hold	9,650	–	–	0.17%	73
2024 Q2	$895K	Hold	9,650	–	–	0.15%	69
2024 Q1	$916K	Sell	9,650 -1,800	-16%	-$167K	0.3%	57
2023 Q4	$1.02M	Hold	11,450	–	–	0.25%	71
2023 Q3	$836K	Hold	11,450	–	–	0.2%	88
2023 Q2	$953K	Hold	11,450	–	–	0.27%	83
2023 Q1	$873K	Hold	11,450	–	–	0.25%	79
2022 Q4	$950K	Hold	11,450	–	–	0.23%	100
2022 Q3	$908K	Hold	11,450	–	–	0.12%	172
2022 Q2	$850K	Hold	11,450	–	–	0.1%	170
2022 Q1	$1.03M	Buy	+11,450	New	+$1.06M	0.12%	178
2019 Q1	–	Sell	-30,000	Closed	-$2.15M	–	155
2018 Q4	$2.15M	Buy	+30,000	New	+$2.42M	0.22%	58
2018 Q1	–	Sell	-121	Closed	-$10K	–	337
2017 Q4	$10K	Hold	121	–	–	﹤0.01%	327
2017 Q3	$10K	Sell	121 -29,750	-100%	-$2.39M	﹤0.01%	302
2017 Q2	$2.31M	Buy	+29,871	New	+$2.12M	0.12%	159
2017 Q1	–	Sell	-1,821	Closed	-$122K	–	390
2016 Q4	$108K	Buy	+1,821	New	+$112K	0.01%	323

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Ionic Capital Management's XBI Position: Q4 2024 in Review

Ionic Capital Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2024, closing a stake of 9,650 shares — an estimated $953K sold.

Ionic Capital Management first reported a position in XBI in Q4 2016 and held it in 16 quarters. The position peaked at $2.31M in Q2 2017. 738 funds tracked by Wall St. Rank hold XBI as of Q4 2024.

Ionic Capital Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2024 after selling out during the quarter.
Ionic Capital Management sold 9,650 State Street SPDR S&P Biotech ETF shares in Q4 2024, an estimated $953K.
Ionic Capital Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2016 and held it in 16 quarters.
Ionic Capital Management's State Street SPDR S&P Biotech ETF position peaked at $2.31M in Q2 2017.
738 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2024.

Based on Ionic Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.